| ASSET | YEAR | % RETURN |
|---|---|---|
Skeena Resources (SKE) | 2011 | -87.39% |
Harrow Health (HROW) | 2011 | -84.81% |
CorMedix (CRMD) | 2011 | -84.74% |
DHT (DHT) | 2011 | -84.32% |
Daqo New Energy Corp ADR (DQ) | 2011 | -83.85% |
Lithium Argentina (LAR) | 2011 | -82.67% |
Pacific Biosciences of California (PACB) | 2011 | -82.62% |
SIGA Technologies (SIGA) | 2011 | -82.25% |
Microvision (MVIS) | 2011 | -80.85% |
Know Labs (KNW) | 2011 | -80.3% |
Gyre Therapeutics (GYRE) | 2011 | -79.19% |
Canadian Solar (CSIQ) | 2011 | -78.79% |
Eyepoint Pharmaceuticals (EYPT) | 2011 | -78.15% |
XOMA (XOMA) | 2011 | -77.8% |
Savara (SVRA) | 2011 | -77.39% |
Newegg Commerce (NEGG) | 2011 | -77.1% |
Transcontinental Realty Investors (TCI) | 2011 | -76.5% |
JinkoSolar (JKS) | 2011 | -75.63% |
Byrna Technologies (BYRN) | 2011 | -73.17% |
Ur Energy (URG) | 2011 | -72.99% |
Geron (GERN) | 2011 | -71.65% |
Teekay Tankers (TNK) | 2011 | -71.2% |
ANI Pharmaceuticals (ANIP) | 2011 | -70.46% |
Altimmune (ALT) | 2011 | -70.33% |
MannKind (MNKD) | 2011 | -69.62% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
